Filter
1256
Text search:
drug
susceptibility
Featured
Recommendations
155
New Publications
301
Language
Document type
No document type
682
Studies & Reports
221
Guidelines
210
Manuals
59
Strategic & Response Plan
37
Fact sheets
20
Training Material
14
Situation Updates
10
Online Courses
2
Infographics
1
Countries / Regions
India
63
Western and Central Europe
43
Ethiopia
32
Eastern Europe
31
Kenya
28
Global
27
South Africa
26
Latin America and the Carribbean
24
Tanzania
21
Zambia
19
Nigeria
18
Nepal
18
Africa
18
Bangladesh
16
Uganda
14
Philippines
14
Malawi
13
Ghana
11
Rwanda
11
Asia
11
Liberia
10
Zimbabwe
10
Namibia
9
South–East Asia Region
9
Cambodia
8
Ukraine
8
Sierra Leone
7
Mozambique
6
Peru
6
Eswatini/ Swaziland
6
Russia
6
Pakistan
5
Botswana
5
Lesotho
5
Myanmar / Burma
5
Cameroon
4
Colombia
4
Western Pacific Region
4
Tajikistan
4
Vietnam
4
Burkina Faso
3
Senegal
3
Germany
3
Syria
3
Sudan
3
Brazil
3
Albania
3
Laos
3
Spain
3
Congo, Democratic Republic of
2
USA
2
Saudi Arabia
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Turkey
2
Thailand
2
Indonesia
2
Argentina
2
Ecuador
2
Sri Lanka
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Fiji
2
Bhutan
2
Venezuela
2
Iran
2
Georgia
2
North America
2
Gabon
2
United Kingdom
2
Mali
1
Morocco
1
Haiti
1
Gambia
1
China
1
Ireland
1
Papua New Guinea
1
Benin
1
North Macedonia
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
East and Southern Africa
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
390
Clinical Guidelines
152
Public Health
60
Women & Child Health
26
Key Resources
24
Pharmacy & Technologies
18
Capacity Building
16
Toolboxes
TB
361
AMR
186
HIV
107
NTDs
57
COVID-19
43
Mental Health
37
Malaria
26
Planetary Health
22
Rapid Response
21
Pharmacy
18
Ebola & Marburg
14
Refugee
14
Caregiver
12
Cholera
11
Polio
11
Global Health Education
11
NCDs
11
2.0 Rapid Response
9
Conflict
7
Natural Hazards
7
Specific Hazards
5
Disability
4
Zika
3
Health Financing Toolbox
1
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Moz
...
Int J Tuberc Lung Dis. 2019 Jul 1;23(7):858–864.Namibia ranks among the 30 high TB burden countries worldwide. Here, we report results of the second nationwide anti-TB drug resistance survey. To assess the prevalence and trends of multidrug-resist
...
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinica
...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im
...
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In
...
Western Pac Surveill Response J. 2014 Oct-Dec; 5(4): 34–46.
Published online 2014 Dec 18. doi: [10.5365/WPSAR.2014.5.4.007]
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region was 52 500 cases
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implement
...
Presentation
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan
...
A survival guide for clinicans.
3rd edition.
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996